Onciu Mihaela, Estey Elihu, Giles Francis J
Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.
Hematology. 2003 Oct;8(5):295-301. doi: 10.1080/10245330310001604737.
We assessed the incidence of circulating blasts occurring post-chemotherapy in 1000 consecutive pediatric blood samples. Blasts with myeloid morphology (<1-3%) were present in post-chemotherapy samples in 19 of 294 (6.4%) patients with acute leukemia in remission and in 11 of 361 (3.4%) patients with solid tumors, non-Hodgkin or Hodgkin lymphoma, and were associated with ANC>1.5x10(9)/l in 13 of 30 (43%) samples, and platelets >100x10(9)/l in 25 of 30 (83%) samples. Our findings suggest that the absence of circulating blasts may not be a prerequisite for remission in acute myeloid leukemia (AML).
我们评估了1000份连续的儿科血液样本化疗后循环原始细胞的发生率。在294例急性白血病缓解期患者中的19例(6.4%)以及361例实体瘤、非霍奇金或霍奇金淋巴瘤患者中的11例(3.4%)的化疗后样本中存在具有髓系形态的原始细胞(<1 - 3%),在30份样本中的13份(43%)中原始细胞与中性粒细胞计数>1.5×10⁹/L相关,在30份样本中的25份(83%)中与血小板>100×10⁹/L相关。我们的研究结果表明,循环原始细胞的缺失可能不是急性髓系白血病(AML)缓解的先决条件。